Biotech Values

[DewDiligence]

Excellent. Both of the factors you present are consequential to a much greater extent than the typical biotech investor understands.

What you’re calling “Survivorship Bias” I like to call program-survival bias so as to make it clear that it has nothing at all to do with patient survival (#msg-4702062).

Suggestion: anyone who does fully comprehend zebra’s post should print it out and contemplate it over and over until they do. These are among the most important concepts in biotech investing!